Criteria for the control of drug-resistant tuberculosis

Proceedings of the National Academy of Sciences of the United States of America

Volumn 97, Issue 14, 2000, Pages 8180-8185

  Dye, Christopher ^a   Williams, Brian G ^b  

^a WORLD HEALTH ORGANIZATION   (Switzerland)

^b DSI CSIR Nanotechnology Innovation Centre   (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

ISONIAZID; RIFAMPICIN;

ARTICLE; CHEMOTHERAPY; EPIDEMIC; HEALTH CARE MANAGEMENT; HEALTH CARE POLICY; HEALTH PROGRAM; INFECTION CONTROL; MULTIDRUG RESISTANCE; PRIORITY JOURNAL; TUBERCULOSIS;

ANTITUBERCULAR AGENTS; DRUG RESISTANCE, MULTIPLE; HUMANS; ISONIAZID; MODELS, THEORETICAL; PRACTICE GUIDELINES; RIFAMPIN; TUBERCULOSIS, PULMONARY; WORLD HEALTH ORGANIZATION;

EID: 0034608891     PISSN: 00278424     EISSN: None     Source Type: Journal    
DOI: 10.1073/pnas.140102797     Document Type: Article

References (25)